Brittenham Marissa (CIK 1908044) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-16). Recent activity: Sell SGRY (3,657 shares), Sell SGRY (8,785 shares), Buy SGRY (17,717 shares), Buy SGRY (16,363 shares), Buy SGRY (9,150 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-16 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Sell | 3,657 | $45,859 |
| 2026-03-09 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Sell | 8,785 | $120,354 |
| 2026-03-09 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Buy | 17,717 | $249,987 |
| 2026-03-09 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Buy | 16,363 | $230,882 |
| 2026-03-09 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Buy | 9,150 | $129,106 |
| 2025-03-13 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Sell | 3,156 | $76,028 |
| 2025-03-06 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Buy | 10,084 | $239,999 |
| 2025-03-06 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Buy | 6,302 | $149,988 |
| 2025-02-10 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Sell | 14,700 | $376,467 |
| 2025-02-04 | Surgery Partners, Inc. (SGRY) | Chief Strategy Officer | Buy | 25,110 | $0 |
Source: SEC Form 4 filings · as of 2026-03-16